Search

Your search keyword '"De Luca, Stefano"' showing total 8 results
Start Over Author "De Luca, Stefano" Journal minerva urology and nephrology
8 results on '"De Luca, Stefano"'

1. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer

Author

AMPARORE, Daniele, primary, DE CILLIS, Sabrina, additional, GRANATO, Stefano, additional, ORTENZI, Michele, additional, DELLA CORTE, Marcello, additional, SICA, Michele, additional, PIANA, Alberto, additional, VERRI, Paolo, additional, DE LUCA, Stefano, additional, MANFREDI, Matteo, additional, FIORI, Cristian, additional, MENGOZZI, Giulio, additional, BERGAMASCHI, Enrico, additional, MARIELLA, Giuseppe, additional, OCCHIPINTI, Sergio, additional, and PORPIGLIA, Francesco, additional

Published
2024
Full Text
View/download PDF

2. Initial experience with robot-assisted ureteroscopy with Ily® Robot

Author

FIORI, Cristian, primary, COSSU, Marco, additional, POGGIO, Massimiliano, additional, QUARÀ, Alberto, additional, DIDIO, Michele, additional, DE LUCA, Stefano, additional, CHECCUCCI, Enrico, additional, MANFREDI, Matteo, additional, AMPARORE, Daniele, additional, and PORPIGLIA, Francesco, additional

Published
2023
Full Text
View/download PDF

3. A prospective randomized controlled trial comparing target prostate biopsy alone approach vs. target plus standard in naïve patients with positive mpMRI

Author

PORPIGLIA, Francesco, primary, CHECCUCCI, Enrico, additional, DE CILLIS, Sabrina, additional, PIRAMIDE, Federico, additional, AMPARORE, Daniele, additional, PIANA, Alberto, additional, VOLPI, Gabriele, additional, GRANATO, Stefano, additional, ZAMENGO, Davide, additional, STURA, Ilaria, additional, ALLADIO, Eugenio, additional, MIGLIARETTI, Giuseppe, additional, DE LUCA, Stefano, additional, BOLLITO, Enrico, additional, GNED, Dario, additional, DI DIO, Michele, additional, AUTORINO, Riccardo, additional, MANFREDI, Matteo, additional, and FIORI, Cristian, additional

Published
2023
Full Text
View/download PDF

4. MRI/real-time ultrasound image fusion guided high-intensity focused ultrasound (HIFU): a prospective comparative and functional analysis of different ablative techniques

Author

DE LUCA, Stefano, primary, CHECCUCCI, Enrico, additional, PIRAMIDE, Federico, additional, RUSSO, Filippo, additional, ALESSIO, Paolo, additional, GARROU, Diletta, additional, PERETTI, Dario, additional, SICA, Michele, additional, VOLPI, Gabriele, additional, PIANA, Alberto, additional, DE CILLIS, Sabrina, additional, AMPARORE, Daniele, additional, MANFREDI, Matteo, additional, FIORI, Cristian, additional, and PORPIGLIA, Francesco, additional

Published
2022
Full Text
View/download PDF

6. Prospective evaluation of urinary steroids and prostate carcinoma-induced deviation: preliminary results

Author

DE LUCA, Stefano, primary, AMANTE, Eleonora, additional, FIORI, Cristian, additional, ALLEVA, Giorgio, additional, ALLADIO, Eugenio, additional, MARINI, Federico, additional, GARROU, Diletta, additional, MANFREDI, Matteo, additional, AMPARORE, Daniele, additional, CHECCUCCI, Enrico, additional, PRUNER, Serena, additional, SALOMONE, Alberto, additional, SCARPA, Roberto M., additional, VINCENTI, Marco, additional, and PORPIGLIA, Francesco, additional

Published
2021
Full Text
View/download PDF

8. MRI/real-time ultrasound image fusion guided high-intensity focused ultrasound: a prospective comparative and functional analysis of different ablative techniques.

Author

DE Luca S, Checcucci E, Piramide F, Russo F, Alessio P, Garrou D, Peretti D, Sica M, Volpi G, Piana A, DE Cillis S, Amparore D, Manfredi M, Fiori C, and Porpiglia F

Subjects
Male, Humans, Prospective Studies, Quality of Life, Ultrasonography methods, Magnetic Resonance Imaging methods, Prostatic Neoplasms diagnostic imaging, Prostatic Neoplasms surgery, Prostatic Neoplasms pathology
Abstract

Background: The aim of this paper was to compare safety and functional outcomes of total, hemi and focal ablation by the latest focal high-intensity focused ultrasound (HIFU) device., Methods: This is a prospective study including patients with low to intermediate-risk PCa treated with HIFU by Focal One ® device from 11/2018 to 3/2020. Before the treatment all patients underwent mp-magnetic resonance imaging (MRI) and subsequent MRI/transrectal ultrasound (TRUS) fusion and standard biopsy. Patients were stratified according to the type of ablation: total, hemi- or focal ablation. Functional data (IPSS, Quality of Life [QoL], IIEF-5, maximum flow [Qmax] and post void residual [PVR] at flowmetry) were assessed preoperatively and at 1, 3, 6 and 12 months after treatment. Moreover, the urinary symptoms reported by patients at IPSS questionnaire were divided in "irritative" and "obstructive" and compared., Results: One hundred patients were enrolled. Median prostate volume and lesion diameter were 46 (IQR 25-75) mL and 10 (IQR 6-13) mm. 15, 50 and 35 patients underwent total, hemi- and focal ablation, respectively. No differences were found between them except for operative time (lower in the focal group, P<0.01). Significant lower incidence of irritative symptoms was identified in the focal group compared to the others (P<0.05 at 1 and 3 months of follow-up). No differences were found among the baseline status and the postoperative assessment in terms of obstructive IPSS items, IIEF-5, QoL, Qmax and PVR (all P value>0.05)., Conclusions: Our study suggests that patients' specific HIFU tailoring with the MRI/real-time TRUS Guidance by Focal One ® device is able to minimize the side effects of treatment.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results